The relative risk reduction for participants who received adintrevimab as post-exposure prophylaxis was 75%.
Monoclonal antibody injection shown to prevent COVID-19 during Delta, Omicron
More from COVID-19More posts in COVID-19 »
- Long-COVID codes in health record may dramatically underestimate its prevalence
- Quick takes: School infection prevention, low US respiratory virus levels, polio in 3 nations
- Study: Kids with long COVID have impaired exercise capacity
- Global meta-analysis estimates 43% rate of multidrug resistance in COVID patients